Search Results: COVID-19 (297)

The receipt of the P145.5 million grant signifies a significant milestone in the Philippines’ ongoing efforts to fortify COVID-19 vaccination and routine immunisation programs. Therefore, the collaboration endeavours to bridge immunisation gaps and achieve optimal vaccination coverage rates with a targeted approach. Additionally, it exhibits a commitment to gender responsiveness and collaborative partnerships. As the nation navigates the complexities of the pandemic, collective action and solidarity remain pivotal in ensuring a healthier, more resilient future for all Filipinos, safeguarding the health and well-being of current and future generations alike.

The Duke-NUS research team, collaborating with Duke University and the National University of Singapore, conducted a preclinical comparison between nasal and subcutaneous administration of the COVID-19 vaccine. Their findings were published in eBioMedicine. It revealed that the intranasal route not only induces a strong mucosal antibody response but also enhances long-term mucosal and systemic immune protection.

Explore the latest developments in the Philippines’ COVID-19 vaccine distribution as the Department of Health halts procurement amid depleted stocks. Committee inquiries, vaccine-associated controversies, and insights from healthcare professionals shed light on the nation’s challenges and successes. Dive into the complex landscape of the ongoing pandemic, where strategic government decisions play a pivotal role in balancing effectiveness, financial sustainability, and healthcare needs.

Dr. Silverose Ann Bacolcol, Head of Manila Doctors’ Hospital Infection Prevention and Control Office, shared that “Most of the COVID-19 cases we see now are mild to moderate infections and can be managed at home. However, patients who have risk factors for disease progression, such as the elderly, those with co-morbid conditions, and are immunocompromised, need close monitoring and may have to be admitted.”

Dr Bacolcol strongly advised to receive a booster shot. She stated, “people should still receive their booster shots for COVID-19 because the threat of COVID-19 infection still exists and will continue to stay. The US CDC and Philippine DOH recommend the COVID-19 booster to prevent serious illness, hospitalisation, and death due to COVID-19.” About 23 million Filipinos have received a booster shot.